ask="3.6000"
ask_size="800"
average_daily_volume="180628"
bid="2.7000"
bid_size="5000"
book_value="3.4050"
change="-0.0469"
change_from_200_day_moving_average="-0.3856"
change_from_50_day_moving_average="-0.0390"
change_from_52_week_high="-4.4469"
change_From_52_week_low="1.0930"
change_in_percent="-1.5686%"
close="2.9431"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-7.4870"
ebitda="-7.62M"
eps_estimate_current_year="-1.1800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-1.2700"
ex_dividend_date="N/A"
float_shares="2302000"
high="2.9900"
high_52_weeks="7.3900"
last_trade_date="3/1/2017"
last_trade_price="2.9431"
last_trade_size="500"
last_trade_time="3:56pm"
low="2.9000"
low_52_weeks="1.8501"
market_capitalization="29.10M"
moving_average_200_day="3.3287"
moving_average_50_day="2.9821"
name="Cesca Therapeutics Inc."
notes="N/A"
one_year_target_price="2.0000"
open="3.0000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-11.5836%"
percent_change_from_50_day_moving_average="-1.3065%"
percent_change_from_52_week_high="-60.1746%"
percent_change_from_52_week_low="+59.0779%"
previous_close="2.9900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8781"
price_per_sales="2.1760"
revenue="13.58M"
shares_outstanding="9886000"
short_ratio="3.8600"
stock_exchange="NCM"
symbol="KOOL"
volume="22036"
weeks_range_52="1.8501 - 7.3900"
